| 产品描述: | HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor with an IC50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs). |
| 靶点: |
HPK1:0.25 nM (IC50) |
| 体内研究: |
HPK1-IN-3 (化合物 27;0.25-4 μM;24 小时) 处理显示促炎细胞因子 IL-6 和 TNF-α 在人单核细胞来源的树突细胞中以浓度依赖性方式显著升高。 |
| 参考文献: |
1. Brandon A Vara, et al. Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Med Chem Lett. 2021 Mar 19;12(4):653-661. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.039 ml |
10.195 ml |
20.389 ml |
| 5 mM |
0.408 ml |
2.039 ml |
4.078 ml |
| 10 mM |
0.204 ml |
1.019 ml |
2.039 ml |
| 50 mM |
0.041 ml |
0.204 ml |
0.408 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |